Oct22023

MHRA authorises monoclonal antibody treatment, Jemperli, to be used with chemotherapy for endometrial cancer

image_pdfimage_print

For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression

Leave a Reply

Your email address will not be published.